Silver Spring, Maryland—(ENEWSPF)—November 17, 2017
By: Theresa Eisenman
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor and are comfortable with the…
